Effects of anti-NKG2A antibody administration on leukemia and normal hematopoietic cells
about
Human NK Cell Subsets Redistribution in Pathological Conditions: A Role for CCR7 ReceptorFunctional Reconstitution of Natural Killer Cells in Allogeneic Hematopoietic Stem Cell TransplantationTrial Watch: Immunotherapy plus radiation therapy for oncological indications.Tonsillar CD56brightNKG2A+ NK cells restrict primary Epstein-Barr virus infection in B cells via IFN-γNatural Killer Cell-Based Cancer Immunotherapies: From Immune Evasion to Promising Targeted Cellular TherapiesMarkers and function of human NK cells in normal and pathological conditions.Modeling Natural Killer Cell Targeted Immunotherapies.Developmental and Functional Control of Natural Killer Cells by Cytokines.High NKG2A expression contributes to NK cell exhaustion and predicts a poor prognosis of patients with liver cancer.Monoclonal Antibody Therapies for Hematological Malignancies: Not Just Lineage-Specific Targets.The early expansion of anergic NKG2Apos/CD56dim/CD16neg natural killer cells represents a therapeutic target in haploidentical haematopoietic stem cell transplantation.High-Risk Leukemia: Past, Present, and Future Role of NK Cells.Next generation immune-checkpoints for cancer therapy.NKG2A Expression Is Not per se Detrimental for the Anti-Multiple Myeloma Activity of Activated Natural Killer Cells in an In Vitro System Mimicking the Tumor Microenvironment.Targeting Checkpoint Receptors and Molecules for Therapeutic Modulation of Natural Killer CellsImmune Cell Hacking: Challenges and Clinical Approaches to Create Smarter Generations of Chimeric Antigen Receptor T CellsNatural Killer Cells in Liver Disease and Hepatocellular Carcinoma and the NK Cell-Based Immunotherapy
P2860
Q28067468-0E4A90D4-DB7D-4DF1-BD34-8D25782FDCB0Q28069682-562FDF91-1C5F-4381-A24A-81B8D492B826Q37308207-C99C9AA3-69A1-48C5-AEAB-BA85185A1D50Q37701554-8FDB2D6D-4EDD-44A3-B98A-924A52634052Q38651290-5659F7F3-14E5-4B6C-B31C-3BA2ECCA8059Q39068084-92564020-BB66-4755-AE4C-238CA3F8BC3BQ39239278-F91CF090-EA57-4DCA-83AC-5A43AB1F3D22Q40086298-ADB8D8A5-1784-4E5A-B1DB-51BDF54A4987Q40333142-31110F82-A257-4782-B719-CB0BF61B642FQ49539698-4CFEF7FD-41DA-4093-8ECF-1F7476781037Q52560280-3806518D-A9B7-4CB8-A2EA-7CD4570EE6E4Q55172823-0CD0DA6E-4A5F-4260-BD56-09C426223132Q55383705-D00C8A15-4B82-47EA-A3EF-2BBE562CD9AEQ55514845-C43CD0B1-0BB8-42B3-BC68-A6C9FC349E57Q56889003-FA9D1622-2628-4DED-9482-78C2B47F2917Q57173949-C8200C28-B8B3-4EB3-B8EA-9FD221136B97Q58764532-C7252F0C-340E-42F3-A75A-152DC497C0F1
P2860
Effects of anti-NKG2A antibody administration on leukemia and normal hematopoietic cells
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 31 December 2015
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Effects of anti-NKG2A antibody administration on leukemia and normal hematopoietic cells
@en
Effects of anti-NKG2A antibody administration on leukemia and normal hematopoietic cells.
@nl
type
label
Effects of anti-NKG2A antibody administration on leukemia and normal hematopoietic cells
@en
Effects of anti-NKG2A antibody administration on leukemia and normal hematopoietic cells.
@nl
prefLabel
Effects of anti-NKG2A antibody administration on leukemia and normal hematopoietic cells
@en
Effects of anti-NKG2A antibody administration on leukemia and normal hematopoietic cells.
@nl
P2093
P2860
P1433
P1476
Effects of anti-NKG2A antibody administration on leukemia and normal hematopoietic cells
@en
P2093
Andrea Velardi
Antonella Mancusi
Antonella Tosti
Elena Urbani
Fabiana Topini
François Romagné
Loredana Ruggeri
Lucia Animobono
Mathieu Bléry
Nicolai Wagtmann
P2860
P304
P356
10.3324/HAEMATOL.2015.135301
P577
2015-12-31T00:00:00Z